AB-FUBICA

AB-FUBICA
法律規範狀態
法律規範	加：Schedule II; 德：NpSG; 英：Class B;
識別資訊
	IUPAC命名法 N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxamide; ;
CAS號	1801338-22-6
ChemSpider	57427397;
UNII	U6SUE53VVY;
化學資訊
化學式	C21H22FN3O2
摩爾質量	367.42 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES O=C(N[C@H](C(N)=O)C(C)C)C1=CN(CC2=CC=C(F)C=C2)C3=CC=CC=C31;
	InChI InChI=1S/C21H22FN3O2/c1-13(2)19(20(23)26)24-21(27)17-12-25(18-6-4-3-5-16(17)18)11-14-7-9-15(22)10-8-14/h3-10,12-13,19H,11H2,1-2H3,(H2,23,26)(H,24,27)/t19-/m0/s1; Key:KTVPQJSKKGZIEA-IBGZPJMESA-N;

AB-FUBICA是一種含氮有機氟化合物，分子式C
21H
22FN
3O
2，能作為大麻素受體的激動劑，其對CB₁和CB₂的EC₅₀分別為21 nM和15 nM^[1]^[2]。

另見

^ Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, et al. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chemical Neuroscience. September 2015, 6 (9): 1546–59. PMID 26134475. doi:10.1021/acschemneuro.5b00112.
^ Qian Z, Hua Z, Liu C, Jia W. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances. Forensic Toxicology. November 2015, 34: 133–143. PMC 4705129 . PMID 26793280. doi:10.1007/s11419-015-0297-2.